Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.10
Bid: 8.70
Ask: 9.50
Change: -0.15 (-1.62%)
Spread: 0.80 (9.195%)
Open: 9.25
High: 9.25
Low: 9.10
Prev. Close: 9.25
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Apr 2018 12:43

RNS Number : 8024L
Scancell Holdings Plc
23 April 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

SCANCELL HOLDINGS PLC

 

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Hygea vct plc

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

18 April 2018

6. Date on which issuer notified (DD/MM/YYYY):

20 April 2018

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.5%

0%

3.5%

374,469,098

Position of previous notification (if

applicable)

4.2%

 

 

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

13,149,730

 

3.5%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Hygea vct plc

3.5%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

London, England

Date of completion

18 April 2018

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVLSDIVFIT
Date   Source Headline
5th Oct 20214:22 pmRNSFirst subject dosed in COVIDITY clinical trial
9th Sep 20214:31 pmRNSPDMR dealing
26th Aug 20217:00 amRNSModi-1 Phase I/II CTA approved by MHRA
17th Aug 20217:00 amRNSScancell selects PharmaJet’s Needle-free Systems
30th Jul 20219:52 amRNSDirector Dealing
29th Jul 20217:00 amRNSCOVIDITY Phase 1 trial application in SA approved
28th Jul 20215:00 pmRNSLindy Durrant appointed CEO of Scancell
22nd Jun 20217:00 amRNSCOVIDITY trial planned in South Africa and UK
15th Jun 20217:00 amRNSAppointment of Joint Broker
8th Jun 20214:41 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20218:49 amRNSDirector Dealing
30th Apr 202110:48 amRNSDirector Dealing
10th Mar 20219:58 amRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:00 pmRNSDirector Dealing
19th Feb 20217:00 amRNSDirector Dealing
17th Feb 20212:04 pmRNSDirector Dealing
16th Feb 20213:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Feb 20213:36 pmRNSStatement regarding share price movement
15th Feb 202111:05 amRNSSecond Price Monitoring Extn
15th Feb 202111:00 amRNSPrice Monitoring Extension
15th Feb 20219:05 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSUpdate on SCIB2 clinical development partnership
29th Jan 20217:00 amRNSInterim Results for the 6 months ended 31 Oct 2020
30th Dec 20202:00 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSCOVID-19 vaccine candidate selected
15th Dec 20203:45 pmRNSDirector Dealing
14th Dec 20201:03 pmRNSDirector Dealing
25th Nov 202011:26 amRNSDirector Dealing
17th Nov 20202:34 pmRNSResults of Annual General Meeting
17th Nov 202012:00 pmRNSAppointment of CMO and Medical Director
13th Nov 202012:36 pmRNSDirector Dealing
10th Nov 20202:44 pmRNSDirector Dealing
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
6th Nov 202011:49 amRNSHolding(s) in Company
5th Nov 202010:51 amRNSResult of Adjourned General Meeting
3rd Nov 20208:33 amRNSHolding(s) in Company
2nd Nov 20205:00 pmRNSConvertible Loan Notes & Total Voting Rights
29th Oct 202010:15 amRNSResult of Open Offer and Adjournment of GM
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.